Design Therapeutics, Inc. (DSGN): Price and Financial Metrics
DSGN Price/Volume Stats
| Current price | $5.06 | 52-week high | $7.77 |
| Prev. close | $4.74 | 52-week low | $2.24 |
| Day low | $4.70 | Volume | 273,600 |
| Day high | $5.15 | Avg. volume | 238,591 |
| 50-day MA | $5.92 | Dividend yield | N/A |
| 200-day MA | $4.83 | Market Cap | 286.50M |
DSGN Stock Price Chart Interactive Chart >
Design Therapeutics, Inc. (DSGN) Company Bio
Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company engages in the development of a program for the treatment of Friedreich's ataxia and degenerative diseases such as Fragile X syndrome and myotonic dystrophy. The company was incorporated in 2017 and is based in Carlsbad, California.
DSGN Price Returns
| 1-mo | -19.04% |
| 3-mo | -10.60% |
| 6-mo | 3.27% |
| 1-year | 111.72% |
| 3-year | -54.70% |
| 5-year | N/A |
| YTD | -17.99% |
| 2024 | 132.83% |
| 2023 | -74.17% |
| 2022 | -52.08% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...